Interventional Oncology Market Research Report by Procedure (Ablation, Particle Embolization, and Radiation Therapy) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Interventional Oncology Market is expected to grow from USD 4,055.21 Million in 2020 to USD 5,643.00 Million by the end of 2025.
2. The Global Interventional Oncology Market is expected to grow from EUR 3,555.69 Million in 2020 to EUR 4,947.89 Million by the end of 2025.
3. The Global Interventional Oncology Market is expected to grow from GBP 3,161.01 Million in 2020 to GBP 4,398.68 Million by the end of 2025.
4. The Global Interventional Oncology Market is expected to grow from JPY 432,794.47 Million in 2020 to JPY 602,251.60 Million by the end of 2025.
5. The Global Interventional Oncology Market is expected to grow from AUD 5,888.71 Million in 2020 to AUD 8,194.39 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Interventional Oncology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Procedure, the Interventional Oncology Market studied across Ablation, Particle Embolization, and Radiation Therapy.
Based on Geography, the Interventional Oncology Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Interventional Oncology Market including Angiodynamics, Atricure, Boston Scientific Ltd, Btg, Cook Medical, Medtronic Plc, Merit Medical, Neuwave Medical, Profound Medical, and Terumo Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Interventional Oncology Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Interventional Oncology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Oncology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Oncology Market?
4. What is the competitive strategic window for opportunities in the Global Interventional Oncology Market?
5. What are the technology trends and regulatory frameworks in the Global Interventional Oncology Market?
6. What are the modes and strategic moves considered suitable for entering the Global Interventional Oncology Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Interventional Oncology Market is expected to grow from USD 4,055.21 Million in 2020 to USD 5,643.00 Million by the end of 2025.
2. The Global Interventional Oncology Market is expected to grow from EUR 3,555.69 Million in 2020 to EUR 4,947.89 Million by the end of 2025.
3. The Global Interventional Oncology Market is expected to grow from GBP 3,161.01 Million in 2020 to GBP 4,398.68 Million by the end of 2025.
4. The Global Interventional Oncology Market is expected to grow from JPY 432,794.47 Million in 2020 to JPY 602,251.60 Million by the end of 2025.
5. The Global Interventional Oncology Market is expected to grow from AUD 5,888.71 Million in 2020 to AUD 8,194.39 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Interventional Oncology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Procedure, the Interventional Oncology Market studied across Ablation, Particle Embolization, and Radiation Therapy.
Based on Geography, the Interventional Oncology Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Interventional Oncology Market including Angiodynamics, Atricure, Boston Scientific Ltd, Btg, Cook Medical, Medtronic Plc, Merit Medical, Neuwave Medical, Profound Medical, and Terumo Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Interventional Oncology Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Interventional Oncology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Oncology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Oncology Market?
4. What is the competitive strategic window for opportunities in the Global Interventional Oncology Market?
5. What are the technology trends and regulatory frameworks in the Global Interventional Oncology Market?
6. What are the modes and strategic moves considered suitable for entering the Global Interventional Oncology Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Procedure Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE
6.1. Introduction
6.2. Ablation
6.3. Particle Embolization
6.4. Radiation Therapy
7. AMERICAS INTERVENTIONAL ONCOLOGY MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Angiodynamics
11.2. Atricure
11.3. Boston Scientific Ltd
11.4. Btg
11.5. Cook Medical
11.6. Medtronic Plc
11.7. Merit Medical
11.8. Neuwave Medical
11.9. Profound Medical
11.10. Terumo Corporation
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Procedure Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE
6.1. Introduction
6.2. Ablation
6.3. Particle Embolization
6.4. Radiation Therapy
7. AMERICAS INTERVENTIONAL ONCOLOGY MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Angiodynamics
11.2. Atricure
11.3. Boston Scientific Ltd
11.4. Btg
11.5. Cook Medical
11.6. Medtronic Plc
11.7. Merit Medical
11.8. Neuwave Medical
11.9. Profound Medical
11.10. Terumo Corporation
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: SCORES
TABLE 40. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RANKING
TABLE 43. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: SCORES
TABLE 40. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RANKING
TABLE 43. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 (USD MILLION)
FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2025
FIGURE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY TYPE
FIGURE 1. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 (USD MILLION)
FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2025
FIGURE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY TYPE
